Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-04

Clinical Trial Update: The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of escitalopram in pediatric major depressive disorder completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lexapro (escitalopram)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-11-04